Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Okano

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Auris, Nasus, Larynx|December 1, 2015
Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patientsKeisuke Masuyama, Minoru Goto, Sachio Takeno, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 14, 2017
Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trialTakao Fujisawa, Terufumi Shimoda, Keisuke Masuyama, et al.
Scientific Reports|August 1, 2018
Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polypsTakahiro Ninomiya, Emiko Noguchi, Takenori Haruna, et al.
American Journal of Rhinology & Allergy|April 12, 2021
A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic RhinosinusitisTetsuji Takabayashi, Daiya Asaka, Yoshitaka Okamoto, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2025
Tezepelumab inhibits highly functional truncated thymic stromal lymphopoietin in chronic rhinosinusitisAiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 19, 2020
Serum IgG4 as a biomarker reflecting pathophysiology and post-operative recurrence in chronic rhinosinusitisAiko Oka, Takahiro Ninomiya, Tazuko Fujiwara, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|July 1, 2020
Strategic Outlook toward 2030: Japan's research for allergy and immunology - Secondary publicationTakeya Adachi, Keigo Kainuma, Koichiro Asano, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2025
Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polypsAiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2026
Heterogeneity and Clinical Relevance of Group 2 Innate Lymphoid Cells Subsets in Nasal PolypsMasanori Kidoguchi, Naruhito Iwasaki, Julie A Poposki, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|August 19, 2019
Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tabletMinoru Gotoh, Kimihiro Okubo, Atsushi Yuta, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Auris, Nasus, Larynx|December 1, 2015
Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patientsKeisuke Masuyama, Minoru Goto, Sachio Takeno, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 14, 2017
Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trialTakao Fujisawa, Terufumi Shimoda, Keisuke Masuyama, et al.
Scientific Reports|August 1, 2018
Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polypsTakahiro Ninomiya, Emiko Noguchi, Takenori Haruna, et al.
American Journal of Rhinology & Allergy|April 12, 2021
A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic RhinosinusitisTetsuji Takabayashi, Daiya Asaka, Yoshitaka Okamoto, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2025
Tezepelumab inhibits highly functional truncated thymic stromal lymphopoietin in chronic rhinosinusitisAiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 19, 2020
Serum IgG4 as a biomarker reflecting pathophysiology and post-operative recurrence in chronic rhinosinusitisAiko Oka, Takahiro Ninomiya, Tazuko Fujiwara, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|July 1, 2020
Strategic Outlook toward 2030: Japan's research for allergy and immunology - Secondary publicationTakeya Adachi, Keigo Kainuma, Koichiro Asano, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2025
Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polypsAiko Oka, Aiko I Klingler, Masanori Kidoguchi, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2026
Heterogeneity and Clinical Relevance of Group 2 Innate Lymphoid Cells Subsets in Nasal PolypsMasanori Kidoguchi, Naruhito Iwasaki, Julie A Poposki, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|August 19, 2019
Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tabletMinoru Gotoh, Kimihiro Okubo, Atsushi Yuta, et al.
Pageof 14